Status:
COMPLETED
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
20-70 years
Phase:
PHASE4
Brief Summary
To estimate the efficacy of combination therapy with Lantus plus Amaryl in controlling blood glucose in Japanese patients with type 2 diabetes having failed OAD therapy, and document the ability to pr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients planned for enrollment into this study had to have noninsulin-dependent diabetes mellitus (NIDDM) (type 2 diabetes) and were not able to maintain good metabolic control with OADs.
- Enrolled patients could be male or female, of documented Japanese ethnic origin, and between the ages of 20 and 70 years, inclusive.
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00642915
Start Date
June 1 2003
End Date
July 1 2004
Last Update
August 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
São Paulo, Brazil